Eli Lilly and Co Q2 2023 Earnings Call Transcript - Thomson StreetEvents

Eli Lilly and Co Q2 2023 Earnings Call Transcript

Eli Lilly and Co Q2 2023 Earnings Call Transcript - Thomson StreetEvents
Eli Lilly and Co Q2 2023 Earnings Call Transcript
Published Aug 08, 2023
Published Aug 08, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of LLY.N earnings conference call or presentation 8-Aug-23 1:00pm GMT

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Eli Lilly and Co
Ticker
LLY.N
Time
1:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Kerry Ann Holford - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst : On the guidance, please, on OpEx. So clearly, operating costs higher than at least, the market anticipated in Q2. And you are now guiding to spend more on SG&A/R&D through this year. So I'm just interested to learn more about what has changed through this quarter to continue to raise that OpEx outlook versus your previous quarter. Can you elaborate on the key drivers of that, please?

Question: Colin Nigel Bristow - UBS Investment Bank, Research Division - Analyst : Congrats on the quarter. I heard the sort of positive commentary regarding the commercial supply coming online at RTP. And just as we think about '24, how likely is it or what do you foresee in terms of supply potentially capping the sales potential in '24? And is the decision to move forward with the vials and multi-dose pen in any way related to delays at the RTP side?

Question: Kerry Ann Holford - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst : Just a quick one on Verzenio. Just interested to see whether you can tender from a proportion of those drug sales now are represented by use in the early breast cancer setting. And given we've now seen the Kisqali NATALEE data at ASCO, just interested to hear how you're thinking about competition coming into that space?

Table Of Contents

Eli Lilly and Co at UBS BioPharma Conference Transcript – 2023-11-08 – US$ 54.00 – Edited Transcript of LLY.N presentation 8-Nov-23 8:00pm GMT

Eli Lilly and Co Q3 2023 Earnings Call Summary – 2023-11-02 – US$ 54.00 – Edited Brief of LLY.N earnings conference call or presentation 2-Nov-23 1:00pm GMT

Eli Lilly and Co Q3 2023 Earnings Call Transcript – 2023-11-02 – US$ 54.00 – Edited Transcript of LLY.N earnings conference call or presentation 2-Nov-23 1:00pm GMT

Eli Lilly and Co at Morgan Stanley Global Healthcare Conference Transcript – 2023-09-11 – US$ 54.00 – Edited Transcript of LLY.N presentation 11-Sep-23 6:55pm GMT

Eli Lilly and Co Q2 2023 Earnings Call Summary – 2023-08-08 – US$ 54.00 – Edited Brief of LLY.N earnings conference call or presentation 8-Aug-23 1:00pm GMT

Eli Lilly and Co to Provide Alzheimer's Disease Update Summary – 2023-07-17 – US$ 54.00 – Edited Brief of LLY.N conference call or presentation 17-Jul-23 5:30pm GMT

Eli Lilly and Co to Provide Alzheimer's Disease Update Transcript – 2023-07-17 – US$ 54.00 – Edited Transcript of LLY.N conference call or presentation 17-Jul-23 5:30pm GMT

Eli Lilly and Co at Goldman Sachs Healthcare Conference Summary – 2023-06-12 – US$ 54.00 – Edited Brief of LLY.N presentation 12-Jun-23 8:20pm GMT

Eli Lilly and Co at Goldman Sachs Healthcare Conference Transcript – 2023-06-12 – US$ 54.00 – Edited Transcript of LLY.N presentation 12-Jun-23 8:20pm GMT

Eli Lilly and Co at Bank of America Global Healthcare Conference Transcript – 2023-05-10 – US$ 54.00 – Edited Transcript of LLY.N presentation 10-May-23 5:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Eli Lilly and Co Q2 2023 Earnings Call Transcript" Aug 08, 2023. Alacra Store. May 12, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2023-Eli-Lilly-and-Co-Earnings-Call-T15413524>
  
APA:
Thomson StreetEvents. (2023). Eli Lilly and Co Q2 2023 Earnings Call Transcript Aug 08, 2023. New York, NY: Alacra Store. Retrieved May 12, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2023-Eli-Lilly-and-Co-Earnings-Call-T15413524>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.